Virco N.V.
5Patents
2Active
5Granted
32Portfolio score
Filing activity: Jul 24, 1998 → Jan 13, 2009 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6221578A | Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7206699B2 | Methods for measuring therapy resistance | Physics | 11 | Expired |
| US6528251B2 | Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8574831B2 | Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance | Physics | 0 | Active |
| US8563236B2 | Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.